Fractional CO 2 laser for treatment of stress urinary incontinence

Fariba Behnia-Willison, Tran T.T. Nguyen, Behrang Mohamadi, Thierry G. Vancaillie, Alan Lam, Nadia N. Willison, Jett Zivkovic, Richard J. Woodman, Monika Skubisz

Research output: Contribution to journalArticle

Abstract

Objectives: To evaluate the impact of trans-vaginal fractional CO 2 laser treatment on symptoms of stress urinary incontinence (SUI) in women. Study design: Women clinically diagnosed with SUI preferring non-surgical treatment were recruited to the study. Fractional CO 2 laser system (MonaLisa T, DEKA) treatments were administered trans-vaginally every 4–6 weeks for a total of three treatments. Response to treatment was assessed at baseline (T1), at 3 months after treatment completion (T2) and at 12–24-month follow-up (T3) using the Australian Pelvic Floor Questionnaire (APFQ). The primary outcome was changes in reported symptoms of SUI. Secondary outcomes assessed included bladder function, urgency, urge urinary incontinence (UUI), pad usage, impact of urinary incontinence on quality of life (QOL) and degree of bothersome bladder. Results: Fifty-eight women were recruited and received the study treatment protocol. Eighty-two percent of participants reported an improvement in symptoms of SUI at completion of treatment (mild to no SUI) (p = <0.01). Treatment effect waned slightly when assessed at follow-up. Nevertheless, 71% of participants reported ongoing improvement in SUI symptoms at 12–24 months (p < 0.01). All secondary outcome measures were improved after treatment compared to baseline. Conclusions: This study suggests that fractional CO 2 laser is a safe, feasible, and beneficial treatment for SUI and may have a role as a minimally-invasive alternative to surgical management.

LanguageEnglish
Article number100004
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology: X
Volume1
DOIs
Publication statusPublished - 1 Jan 2019

Keywords

  • Bladder function
  • Bladder urgency
  • Fractional CO laser
  • Stress urinary incontinence
  • Urinary leakage

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

Behnia-Willison, Fariba ; Nguyen, Tran T.T. ; Mohamadi, Behrang ; Vancaillie, Thierry G. ; Lam, Alan ; Willison, Nadia N. ; Zivkovic, Jett ; Woodman, Richard J. ; Skubisz, Monika. / Fractional CO 2 laser for treatment of stress urinary incontinence In: European Journal of Obstetrics and Gynecology and Reproductive Biology: X. 2019 ; Vol. 1.
@article{6219388e3a53475f9de9050a233b1dd9,
title = "Fractional CO 2 laser for treatment of stress urinary incontinence",
abstract = "Objectives: To evaluate the impact of trans-vaginal fractional CO 2 laser treatment on symptoms of stress urinary incontinence (SUI) in women. Study design: Women clinically diagnosed with SUI preferring non-surgical treatment were recruited to the study. Fractional CO 2 laser system (MonaLisa T, DEKA) treatments were administered trans-vaginally every 4–6 weeks for a total of three treatments. Response to treatment was assessed at baseline (T1), at 3 months after treatment completion (T2) and at 12–24-month follow-up (T3) using the Australian Pelvic Floor Questionnaire (APFQ). The primary outcome was changes in reported symptoms of SUI. Secondary outcomes assessed included bladder function, urgency, urge urinary incontinence (UUI), pad usage, impact of urinary incontinence on quality of life (QOL) and degree of bothersome bladder. Results: Fifty-eight women were recruited and received the study treatment protocol. Eighty-two percent of participants reported an improvement in symptoms of SUI at completion of treatment (mild to no SUI) (p = <0.01). Treatment effect waned slightly when assessed at follow-up. Nevertheless, 71{\%} of participants reported ongoing improvement in SUI symptoms at 12–24 months (p < 0.01). All secondary outcome measures were improved after treatment compared to baseline. Conclusions: This study suggests that fractional CO 2 laser is a safe, feasible, and beneficial treatment for SUI and may have a role as a minimally-invasive alternative to surgical management.",
keywords = "Bladder function, Bladder urgency, Fractional CO laser, Stress urinary incontinence, Urinary leakage",
author = "Fariba Behnia-Willison and Nguyen, {Tran T.T.} and Behrang Mohamadi and Vancaillie, {Thierry G.} and Alan Lam and Willison, {Nadia N.} and Jett Zivkovic and Woodman, {Richard J.} and Monika Skubisz",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.eurox.2019.100004",
language = "English",
volume = "1",
journal = "European Journal of Obstetrics and Gynecology and Reproductive Biology: X",
issn = "2590-1613",
publisher = "Elsevier Ireland Ltd",

}

Behnia-Willison, F, Nguyen, TTT, Mohamadi, B, Vancaillie, TG, Lam, A, Willison, NN, Zivkovic, J, Woodman, RJ & Skubisz, M 2019, ' Fractional CO 2 laser for treatment of stress urinary incontinence ', European Journal of Obstetrics and Gynecology and Reproductive Biology: X, vol. 1, 100004. https://doi.org/10.1016/j.eurox.2019.100004

Fractional CO 2 laser for treatment of stress urinary incontinence . / Behnia-Willison, Fariba; Nguyen, Tran T.T.; Mohamadi, Behrang; Vancaillie, Thierry G.; Lam, Alan; Willison, Nadia N.; Zivkovic, Jett; Woodman, Richard J.; Skubisz, Monika.

In: European Journal of Obstetrics and Gynecology and Reproductive Biology: X, Vol. 1, 100004, 01.01.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fractional CO 2 laser for treatment of stress urinary incontinence

AU - Behnia-Willison, Fariba

AU - Nguyen, Tran T.T.

AU - Mohamadi, Behrang

AU - Vancaillie, Thierry G.

AU - Lam, Alan

AU - Willison, Nadia N.

AU - Zivkovic, Jett

AU - Woodman, Richard J.

AU - Skubisz, Monika

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: To evaluate the impact of trans-vaginal fractional CO 2 laser treatment on symptoms of stress urinary incontinence (SUI) in women. Study design: Women clinically diagnosed with SUI preferring non-surgical treatment were recruited to the study. Fractional CO 2 laser system (MonaLisa T, DEKA) treatments were administered trans-vaginally every 4–6 weeks for a total of three treatments. Response to treatment was assessed at baseline (T1), at 3 months after treatment completion (T2) and at 12–24-month follow-up (T3) using the Australian Pelvic Floor Questionnaire (APFQ). The primary outcome was changes in reported symptoms of SUI. Secondary outcomes assessed included bladder function, urgency, urge urinary incontinence (UUI), pad usage, impact of urinary incontinence on quality of life (QOL) and degree of bothersome bladder. Results: Fifty-eight women were recruited and received the study treatment protocol. Eighty-two percent of participants reported an improvement in symptoms of SUI at completion of treatment (mild to no SUI) (p = <0.01). Treatment effect waned slightly when assessed at follow-up. Nevertheless, 71% of participants reported ongoing improvement in SUI symptoms at 12–24 months (p < 0.01). All secondary outcome measures were improved after treatment compared to baseline. Conclusions: This study suggests that fractional CO 2 laser is a safe, feasible, and beneficial treatment for SUI and may have a role as a minimally-invasive alternative to surgical management.

AB - Objectives: To evaluate the impact of trans-vaginal fractional CO 2 laser treatment on symptoms of stress urinary incontinence (SUI) in women. Study design: Women clinically diagnosed with SUI preferring non-surgical treatment were recruited to the study. Fractional CO 2 laser system (MonaLisa T, DEKA) treatments were administered trans-vaginally every 4–6 weeks for a total of three treatments. Response to treatment was assessed at baseline (T1), at 3 months after treatment completion (T2) and at 12–24-month follow-up (T3) using the Australian Pelvic Floor Questionnaire (APFQ). The primary outcome was changes in reported symptoms of SUI. Secondary outcomes assessed included bladder function, urgency, urge urinary incontinence (UUI), pad usage, impact of urinary incontinence on quality of life (QOL) and degree of bothersome bladder. Results: Fifty-eight women were recruited and received the study treatment protocol. Eighty-two percent of participants reported an improvement in symptoms of SUI at completion of treatment (mild to no SUI) (p = <0.01). Treatment effect waned slightly when assessed at follow-up. Nevertheless, 71% of participants reported ongoing improvement in SUI symptoms at 12–24 months (p < 0.01). All secondary outcome measures were improved after treatment compared to baseline. Conclusions: This study suggests that fractional CO 2 laser is a safe, feasible, and beneficial treatment for SUI and may have a role as a minimally-invasive alternative to surgical management.

KW - Bladder function

KW - Bladder urgency

KW - Fractional CO laser

KW - Stress urinary incontinence

KW - Urinary leakage

UR - http://www.scopus.com/inward/record.url?scp=85061752789&partnerID=8YFLogxK

U2 - 10.1016/j.eurox.2019.100004

DO - 10.1016/j.eurox.2019.100004

M3 - Article

VL - 1

JO - European Journal of Obstetrics and Gynecology and Reproductive Biology: X

T2 - European Journal of Obstetrics and Gynecology and Reproductive Biology: X

JF - European Journal of Obstetrics and Gynecology and Reproductive Biology: X

SN - 2590-1613

M1 - 100004

ER -